{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:57:07Z","timestamp":1771577827939,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T00:00:00Z","timestamp":1432771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1457-9","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T05:05:40Z","timestamp":1432703140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of statin use on volumetric mammographic density: results from the KARMA study"],"prefix":"10.1186","volume":"15","author":[{"given":"Ida","family":"Skarping","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith S.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Signe","family":"Borgquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,28]]},"reference":[{"issue":"16","key":"1457_CR1","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1161\/01.CIR.0000033635.42612.88","volume":"106","author":"DJ Lefer","year":"2002","unstructured":"Lefer DJ. Statins as potent antiinflammatory drugs. Circulation. 2002;106(16):2041\u20132.","journal-title":"Circulation"},{"issue":"1","key":"1457_CR2","first-page":"10","volume":"9","author":"KK Chan","year":"2003","unstructured":"Chan KK, Oza AM, Siu LL. The statins as anticancer agents. Clinical cancer research. 2003;9(1):10\u20139.","journal-title":"Clinical cancer research"},{"issue":"12","key":"1457_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.5414\/CPP42695","volume":"42","author":"AO Muck","year":"2004","unstructured":"Muck AO, Seeger H, Wallwiener D. Inhibitory effect of statins on the proliferation of human breast cancer cells. International journal of clinical pharmacology and therapeutics. 2004;42(12):695\u2013700.","journal-title":"International journal of clinical pharmacology and therapeutics"},{"issue":"2","key":"1457_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10549-013-2473-6","volume":"138","author":"O Bjarnadottir","year":"2013","unstructured":"Bjarnadottir O, Romero Q, Bendahl PO, Jirstrom K, Ryden L, Loman N, et al. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. Breast cancer research and treatment. 2013;138(2):499\u2013508.","journal-title":"Breast cancer research and treatment"},{"issue":"1","key":"1457_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10549-009-0507-x","volume":"119","author":"ER Garwood","year":"2010","unstructured":"Garwood ER, Kumar AS, Baehner FL, Moore DH, Au A, Hylton N, et al. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast cancer research and treatment. 2010;119(1):137\u201344.","journal-title":"Breast cancer research and treatment"},{"issue":"8","key":"1457_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/154099903322447710","volume":"12","author":"JA Cauley","year":"2003","unstructured":"Cauley JA, Zmuda JM, Lui LY, Hillier TA, Ness RB, Stone KL, et al. Lipid-lowering drug use and breast cancer in older women: a prospective study. Journal of Women's Health (1540\u20139996). 2003;12(8):749\u201356.","journal-title":"Journal of Women's Health (1540\u20139996)"},{"issue":"34","key":"1457_CR7","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1200\/JCO.2005.02.7045","volume":"23","author":"S Bonovas","year":"2005","unstructured":"Bonovas S, Filioussi K, Tsavaris N, Sitaras NM. Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies. Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology. 2005;23(34):8606\u201312.","journal-title":"Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology"},{"issue":"10","key":"1457_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/jnci\/djj188","volume":"98","author":"JA Cauley","year":"2006","unstructured":"Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, et al. Statin use and breast cancer: prospective results from the Women's Health Initiative. Journal of the National Cancer Institute: JNCI. 2006;98(10):700\u20137.","journal-title":"Journal of the National Cancer Institute: JNCI"},{"issue":"9","key":"1457_CR9","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1158\/1055-9965.EPI-13-0414","volume":"22","author":"JA McDougall","year":"2013","unstructured":"McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74\u00a0years of age. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2013;22(9):1529\u201337.","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"1","key":"1457_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10549-012-2154-x","volume":"135","author":"K Undela","year":"2012","unstructured":"Undela K, Srikanth V, Bansal D. Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast cancer research and treatment. 2012;135(1):261\u20139.","journal-title":"Breast cancer research and treatment"},{"issue":"12","key":"1457_CR11","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1200\/JCO.2004.02.027","volume":"22","author":"MR Graaf","year":"2004","unstructured":"Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ. The risk of cancer in users of statins. Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology. 2004;22(12):2388\u201394.","journal-title":"Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology"},{"issue":"19","key":"1457_CR12","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","volume":"367","author":"SF Nielsen","year":"2012","unstructured":"Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. The New England journal of medicine. 2012;367(19):1792\u2013802.","journal-title":"The New England journal of medicine"},{"issue":"19","key":"1457_CR13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/jnci\/djr291","volume":"103","author":"TP Ahern","year":"2011","unstructured":"Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, et al. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. Journal of the National Cancer Institute: JNCI. 2011;103(19):1461\u20138.","journal-title":"Journal of the National Cancer Institute: JNCI"},{"issue":"10","key":"1457_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110231","volume":"9","author":"TJ Murtola","year":"2014","unstructured":"Murtola TJ, Visvanathan K, Artama M, Vainio H, Pukkala E. Statin use and breast cancer survival: a nationwide cohort study from Finland. PloS one. 2014;9(10), e110231.","journal-title":"PloS one"},{"issue":"6","key":"1457_CR15","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","volume":"15","author":"VA McCormack","year":"2006","unstructured":"McCormack VA, dos Santos SI. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research. 2006;15(6):1159\u201369.","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research"},{"issue":"15","key":"1457_CR16","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/jnci\/djr225","volume":"103","author":"L Yaghjyan","year":"2011","unstructured":"Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. Journal of the National Cancer Institute. 2011;103(15):1179\u201389.","journal-title":"Journal of the National Cancer Institute"},{"issue":"10","key":"1457_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S1470-2045(05)70390-9","volume":"6","author":"NF Boyd","year":"2005","unstructured":"Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. Mammographic breast density as an intermediate phenotype for breast cancer. The lancet oncology. 2005;6(10):798\u2013808.","journal-title":"The lancet oncology"},{"issue":"3\u20134","key":"1457_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/BD-1998-103-412","volume":"10","author":"NF Boyd","year":"1998","unstructured":"Boyd NF, Lockwood GA, Martin LJ, Knight JA, Byng JW, Yaffe MJ, et al. Mammographic densities and breast cancer risk. Breast disease. 1998;10(3\u20134):113\u201326.","journal-title":"Breast disease"},{"issue":"3","key":"1457_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.7326\/0003-4819-138-3-200302040-00008","volume":"138","author":"PA Carney","year":"2003","unstructured":"Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Annals of internal medicine. 2003;138(3):168\u201375.","journal-title":"Annals of internal medicine"},{"issue":"13","key":"1457_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/jnci\/92.13.1081","volume":"92","author":"MT Mandelson","year":"2000","unstructured":"Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. Journal of the National Cancer Institute. 2000;92(13):1081\u20137.","journal-title":"Journal of the National Cancer Institute"},{"key":"1457_CR21","unstructured":"The KARMA study http:\/\/karmastudy.org\/sources\/"},{"issue":"7","key":"1457_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish Prescribed Drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiology and drug safety. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"1457_CR23","unstructured":"Harvey RHSMBMJYNKJ: Robust Breast Composition Measurement - Volpara\u2122. Digital Mammography 2010(10th International Workshop, IWDM 2010, Girona, Catalonia, Spain, June 16\u201318, 2010. Proceedings):pp 342\u2013349."},{"issue":"9","key":"1457_CR24","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1158\/1055-9965.EPI-13-1219","volume":"23","author":"JS Brand","year":"2014","unstructured":"Brand JS, Czene K, Shepherd JA, Leifland K, Heddson B, Sundbom A, et al. Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014;23(9):1764\u201372.","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"3","key":"1457_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0895-4356(02)00614-5","volume":"56","author":"P Beck","year":"2003","unstructured":"Beck P, Wysowski DK, Downey W, Butler-Jones D. Statin use and the risk of breast cancer. Journal of clinical epidemiology. 2003;56(3):280\u20135.","journal-title":"Journal of clinical epidemiology"},{"key":"1457_CR26","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JA Sterne","year":"2009","unstructured":"Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. Bmj. 2009;338:b2393.","journal-title":"Bmj"},{"key":"1457_CR27","doi-asserted-by":"publisher","DOI":"10.1201\/9781439821862","volume-title":"Analysis of incomplete multivariate data","author":"JL Schafer","year":"1997","unstructured":"Schafer JL. Analysis of incomplete multivariate data. London: Chapman, Hall; 1997."},{"issue":"3","key":"1457_CR28","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10549-011-1858-7","volume":"131","author":"MJ Higgins","year":"2012","unstructured":"Higgins MJ, Prowell TM, Blackford AL, Byrne C, Khouri NF, Slater SA, et al. A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer. Breast cancer research and treatment. 2012;131(3):915\u201324.","journal-title":"Breast cancer research and treatment"},{"issue":"10","key":"1457_CR29","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1016\/S1470-2045(14)70119-6","volume":"15","author":"TP Ahern","year":"2014","unstructured":"Ahern TP, Lash TL, Damkier P, Christiansen PM, Cronin-Fenton DP. Statins and breast cancer prognosis: evidence and opportunities. The lancet oncology. 2014;15(10):e461\u2013468.","journal-title":"The lancet oncology"},{"issue":"21","key":"1457_CR30","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/jnci\/87.21.1622","volume":"87","author":"C Byrne","year":"1995","unstructured":"Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. Journal of the National Cancer Institute: JNCI. 1995;87(21):1622\u20139.","journal-title":"Journal of the National Cancer Institute: JNCI"},{"key":"1457_CR31","doi-asserted-by":"crossref","unstructured":"Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L, Vachon C, Bakker MF, Giles GG, Chia KS et al.: Mammographic Density Phenotypes and Risk of Breast Cancer: A Meta-analysis. Journal of the National Cancer Institute 2014, 106(5).","DOI":"10.1093\/jnci\/dju078"},{"key":"1457_CR32","doi-asserted-by":"crossref","unstructured":"Schetter SE, Hartman TJ, Liao J, Richie JP, Prokopczyk B, DuBrock C, Signori C, Hamilton C, Demers LM, El-Bayoumy K et al.: Differential impact of body mass index on absolute and percent breast density: implications regarding their use as breast cancer risk biomarkers. Breast cancer research and treatment 2014.","DOI":"10.1158\/1538-7445.AM2014-3249"},{"issue":"1","key":"1457_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2009.03.001","volume":"63","author":"JL Bosco","year":"2010","unstructured":"Bosco JL, Silliman RA, Thwin SS, Geiger AM, Buist DS, Prout MN, et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. Journal of clinical epidemiology. 2010;63(1):64\u201374.","journal-title":"Journal of clinical epidemiology"},{"issue":"12","key":"1457_CR34","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1200\/JCO.2010.31.5200","volume":"29","author":"CM Kitahara","year":"2011","unstructured":"Kitahara CM, Berrington de Gonzalez A, Freedman ND, Huxley R, Mok Y, Jee SH, et al. Total cholesterol and cancer risk in a large prospective study in Korea. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(12):1592\u20138.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"15","key":"1457_CR35","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/jnci\/djh216","volume":"96","author":"AS Furberg","year":"2004","unstructured":"Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. Journal of the National Cancer Institute. 2004;96(15):1152\u201360.","journal-title":"Journal of the National Cancer Institute"},{"key":"1457_CR36","doi-asserted-by":"crossref","unstructured":"Martin LJ, Melnichouk O, Huszti E, Connelly PW, Greenberg CV, Minkin S, Boyd NF: Serum lipids, lipoproteins, and risk of breast cancer: a nested case\u2013control study using multiple time points. Journal of the National Cancer Institute 2015, 107(5).","DOI":"10.1093\/jnci\/djv032"},{"issue":"12","key":"1457_CR37","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrc1751","volume":"5","author":"MF Demierre","year":"2005","unstructured":"Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nature Reviews Cancer. 2005;5(12):930\u201342.","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"1457_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","volume":"19","author":"M Schachter","year":"2005","unstructured":"Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundamental & Clinical Pharmacology. 2005;19(1):117\u201325.","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"11","key":"1457_CR39","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1124\/dmd.30.11.1158","volume":"30","author":"K Nezasa","year":"2002","unstructured":"Nezasa K, Higaki K, Matsumura T, Inazawa K, Hasegawa H, Nakano M, et al. Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin. Drug metabolism and disposition : the biological fate of chemicals. 2002;30(11):1158\u201363.","journal-title":"Drug metabolism and disposition : the biological fate of chemicals"},{"issue":"1","key":"1457_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","volume":"19","author":"BA Hamelin","year":"1998","unstructured":"Hamelin BA, Turgeon J. Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends in pharmacological sciences. 1998;19(1):26\u201337.","journal-title":"Trends in pharmacological sciences"},{"issue":"2","key":"1457_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.canlet.2004.11.011","volume":"224","author":"LM Berstein","year":"2005","unstructured":"Berstein LM. Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer. Cancer Letters. 2005;224(2):203\u201312.","journal-title":"Cancer Letters"},{"issue":"1","key":"1457_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/jnci\/95.1.30","volume":"95","author":"GA Greendale","year":"2003","unstructured":"Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. Journal of the National Cancer Institute: JNCI. 2003;95(1):30\u20137.","journal-title":"Journal of the National Cancer Institute: JNCI"},{"issue":"8","key":"1457_CR43","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1200\/JCO.2007.13.4338","volume":"26","author":"A Fournier","year":"2008","unstructured":"Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F. Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2008;26(8):1260\u20138.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"10","key":"1457_CR44","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/ijc.22542","volume":"120","author":"S Borgquist","year":"2007","unstructured":"Borgquist S, Anagnostaki L, Jirstrom K, Landberg G, Manjer J. Breast tumours following combined hormone replacement therapy express favourable prognostic factors. International journal of cancer Journal international du cancer. 2007;120(10):2202\u20137.","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"19","key":"1457_CR45","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/jnci\/djt243","volume":"105","author":"GN Farhat","year":"2013","unstructured":"Farhat GN, Parimi N, Chlebowski RT, Manson JE, Anderson G, Huang AJ, et al. Sex hormone levels and risk of breast cancer with estrogen plus progestin. Journal of the National Cancer Institute. 2013;105(19):1496\u2013503.","journal-title":"Journal of the National Cancer Institute"},{"issue":"6162","key":"1457_CR46","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.1241908","volume":"342","author":"ER Nelson","year":"2013","unstructured":"Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science. 2013;342(6162):1094\u20138.","journal-title":"Science"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1457-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1457-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1457-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1457-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T15:14:26Z","timestamp":1630595666000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1457-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,28]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1457"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1457-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,28]]},"assertion":[{"value":"8 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"435"}}